Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ALB | P02768 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | AHCY | P23526 | 7/20 | 0.46 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8883524 | 0.87 | AHCY (0.60) | ADORA3ALDH1A1LMNAALBMAPK1 | |
| SCHEMBL29885678 | 0.86 | AHCY (0.63) | ADORA3ALDH1A1LMNAALBMAPK1 | |
| SCHEMBL11161954 | 0.82 | AHCY (0.63) | ADORA3ALDH1A1LMNAALBMAPK1 | |
| SCHEMBL28130881 | 0.82 | AHCY (0.63) | ADORA3ALDH1A1LMNAALBMAPK1 | |
| SCHEMBL8885578 | 0.79 | ADORA3 (0.48) | ADORA3ALDH1A1LMNAALBMAPK1 | |
| SCHEMBL9310418 | 0.78 | ALDH1A1 (0.58) | ADORA3ALDH1A1LMNAALBMAPK1 | |
| SCHEMBL21356436 | 0.74 | ADORA3 (0.50) | ADORA3ALDH1A1LMNAALBMAPK1 | |
| SCHEMBL8885984 | 0.74 | ADORA3 (0.50) | ADORA3ALDH1A1LMNAALBMAPK1 | |
| SCHEMBL8537379 | 0.73 | ALDH1A1 (0.56) | ADORA3ALDH1A1LMNAALBMAPK1 | |
| SCHEMBL8338176 | 0.73 | ALDH1A1 (0.56) | ADORA3ALDH1A1LMNAALBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111511754-A | 2'3' cyclic dinucleotides with phosphonate linkages that activate STING transducins | 捷克共和国有机化学与生物化学研究所 | 2020-08-07 | — | — | CN | disclosed |